NCT00412074View on ClinicalTrials.gov

Establishing the Vitamin D Requirements During Lactation

PHASE3CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Vitamin D Deficiency
Interventions
DRUG

400 IU Vitamin D3 (cholecalciferol)

400 IU vitamin D3/day given to lactating mother and 400 IU vitamin D3/day given as oral supplement to her infant

DRUG

2400 IU Vitamin D3 (cholecalciferol)

2400 IU vitamin D3/day given to lactating mother and 0 IU vitamin D3/day (placebo) given as oral supplement to her infant

DRUG

6400 IU Vitamin D3 (cholecalciferol)

6400 IU vitamin D3/day given to lactating mother and 0 IU vitamin D3/day (placebo) given as oral supplement to her infant

Trial Locations (2)

14642

University of Rochester Medical Center, Rochester

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Medical University of South Carolina

OTHER

NCT00412074 - Establishing the Vitamin D Requirements During Lactation | Biotech Hunter | Biotech Hunter